Department of Medicine, School of Medicine; University of California; San Diego, La Jolla, California USA.
Organogenesis. 2008 Jul;4(3):137-43. doi: 10.4161/org.4.3.6498.
Renal replacement therapy (i.e., kidney transplantation) represents the optimal treatment for end-stage renal disease (a condition which is expected to increase in prevalence). However, the demand for transplantable kidneys currently outpaces the availability of donor kidneys, a situation not expected to improve in the foreseeable future. An alternative route to cadaveric or living-related donors would be to engineer kidneys for allograft transplantation from cells based on concepts derived from current understanding of normal kidney development. Although the use of cells for this purpose remains hypothetical, recent research from our laboratory has provided strong evidence that implantation of kidney-like tissue bioengineered from the recombination of in vitro culture systems which model discrete aspects of kidney development (i.e., cell culture, isolated WD, isolated UB and isolated MM) is possible. These recent findings are discussed here. Pathway based system biology approaches to understanding the mechanism(s) of kidney development are also discussed, particularly in the setting of this novel and seemingly powerful xeno-based tissue engineering strategy.
肾脏替代疗法(即肾移植)是治疗终末期肾病(一种预计发病率会增加的疾病)的最佳方法。然而,目前对可移植肾脏的需求超过了供体肾脏的供应,这种情况预计在可预见的未来不会得到改善。替代尸体或活体相关供体的一种方法是根据当前对正常肾脏发育的理解,从细胞工程设计用于同种异体移植的肾脏。尽管出于这个目的使用细胞仍然是假设的,但我们实验室的最新研究提供了强有力的证据,证明从体外培养系统的重组中植入类似于肾脏的组织是可能的,这些体外培养系统模型是肾脏发育的离散方面(即细胞培养、分离的 WD、分离的 UB 和分离的 MM)。本文讨论了这些最新发现。还讨论了基于途径的系统生物学方法来理解肾脏发育的机制,特别是在这种新颖且看似强大的基于异种的组织工程策略的背景下。